Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 102 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,057,000 | -4.7% | 212,018 | 0.0% | 0.09% | -11.0% |
| Q2 2022 | $3,208,000 | -79.1% | 212,018 | -40.3% | 0.10% | -59.8% |
| Q2 2020 | $15,352,000 | +27.0% | 355,366 | -32.0% | 0.25% | -21.0% |
| Q1 2020 | $12,085,000 | -31.2% | 522,480 | -7.1% | 0.32% | -9.7% |
| Q4 2019 | $17,570,000 | -21.1% | 562,237 | -34.2% | 0.35% | -41.8% |
| Q3 2019 | $22,280,000 | – | 854,940 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $108,639,000 | 6.47% |
| Memorial Sloan Kettering Cancer Center | 216,916 | $10,740,000 | 4.55% |
| Burrage Capital Management LLC | 114,962 | $5,692,000 | 4.34% |
| MPM BioImpact LLC | 674,582 | $33,398,000 | 2.88% |
| First Light Asset Management, LLC | 635,652 | $31,471,000 | 2.33% |
| Cormorant Asset Management, LP | 1,661,647 | $82,268,000 | 1.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 219,419 | $10,863,000 | 1.05% |
| ORACLE INVESTMENT MANAGEMENT INC | 126,342 | $6,255,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 131,016 | $6,487,000 | 0.58% |
| Artal Group S.A. | 285,028 | $14,112,000 | 0.30% |